top of page

Why Choose Hydra by SMT?

Child on Wheelchair

High procedural success rates and favorable clinical outcomes

Excellent hemodynamic performance and leaflet durability

Proven ease of use and accurate deployment

Designed to reduce calcification and extend valve life

Clinical Experience & Evidence

Hydra CE Study (n = 157 patients)

(Journal Reference: JACC: Cardiovascular Interventions, Jan 2022)

  • Sustained single-digit mean aortic gradient up to 1 year

  • Larger Effective Orifice Area (EOA) maintained through follow-up

  • Excellent procedural success and long-term valve competence

Key Data Highlights:
  • Pre-procedure gradient: 49.5 ± 18.5 mmHg

  • 30-day gradient: 8.0 ± 3.6 mmHg

  • 1-year gradient: 8.8 ± 4.7 mmHg

  • 1-year EOA: 1.9 ± 0.6 cm²

  • P < 0.001 for all post-implant improvements

Ordering Information

Hydra Valve Sizes:

  • HYDRA22 – 22 mm

  • HYDRA26 – 26 mm

  • HYDRA30 – 30 mm

 

All models feature bioprosthetic bovine pericardial leaflets with a supra-annular configuration.

Key Features of the Hydra TAVI System

Self-Expandable Nitinol Frame

Conforms precisely to the native aortic annulus with excellent radial strength.

Three Tentacle Design

Secures anatomical anchoring and stability post-deployment.

Large Frame Cells (≥15F)

Facilitates easy access to coronary arteries during future interventions.

Extended Sealing Skirt

Minimizes paravalvular leakage and improves long-term valve competence.

Supra-Annular Valve Leaflets

Optimized leaflet position enhances flow, reduces pressure gradient, and maintains valve shape in elliptical anatomies.

Single Bovine Pericardium Construction

Improved durability and performance with proprietary anti-calcification treatment.

0_edited.jpg
0-Photoroom.png

SMT TAVI – Hydra

Treadstone Allianz Pvt. Ltd. proudly partners with Sahajanand Medical Technologies (SMT) to bring cutting-edge cardiovascular innovations to healthcare providers across India. Hydra is SMT’s flagship TAVI system, designed for minimally invasive aortic valve replacement — offering proven hemodynamic performance, excellent clinical outcomes, and streamlined deliverability.

Delivered by Treadstone Allianz Pvt. Ltd.

As a trusted distribution partner of SMT, Treadstone ensures Hydra is available to top hospitals with expert support, fast logistics, and in-theater clinical guidance when needed.

bottom of page